MedPath

Korean Epilepsy Society

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website
http://www.kes.or.kr/

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Lamotrigine Cognitive Function Study in Adult Untreated Epilepsies

Phase 4
Completed
Conditions
Epilepsy
Interventions
First Posted Date
2009-05-12
Last Posted Date
2009-05-12
Lead Sponsor
Korean Epilepsy Society
Target Recruit Count
121
Registration Number
NCT00896987
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.